In 2024, INTCO Medical, globally recognized as the largest latex-free disposable gloves manufacturer, demonstrated remarkable resilience amid complex global market challenges, delivering a stellar performance that solidified its leadership in medical consumables and healthcare innovation. The company’s annual report highlights breakthroughs in financial metrics, technological advancements, and sustainable practices, underscoring its commitment to driving global health standards.

Financial Excellence: A Testament to Strategic Agility

INTCO Medical’s 2024 financial results reflect a robust operational strategy and market adaptability.    Revenue surged to ¥9.523 billion (approximately $1.3 billion), marking a 37.65% year-on-year increase.  Cash flow from operations reached ¥1.079 billion, up 114.78% year-over-year, signaling strong liquidity and financial stability, and shareholders’ equity grew 8.58% to ¥17.404 billion as a result of reinvestment in production capacity and R&D.    These achievements position INTCO as a financially resilient leader in the medical supply sector.

Unmatched Manufacturing Scale and Efficiency

As the largest latex-free disposable gloves manufacturer, INTCO Medical operates seven strategically located production bases across China and Vietnam, enabling 100% capacity utilization in 2024. The company’s annual production capacity reached 56 billion nitrile gloves and 31 billion PVC gloves, reinforcing its dominance in global markets. This scale ensures consistent supply to over 120 countries, supporting healthcare systems, industrial sectors, and households worldwide by leveraging decades of technical expertise and seamless cross-border logistics.

Innovation-Driven Product Portfolio

INTCO Medical invested ¥398 million in R&D in 2024, focusing on material science and smart manufacturing to drive product innovation. Key advancements included the launch of eco-friendly solutions such as biodegradable nitrile gloves and EU-standard low-weight nitrile gloves, aligning with global sustainability goals, as well as Dust-free clean nitrile gloves designed for sterile environments and syntex™ synthetic latex gloves for users with latex allergies.

The company also expanded into rehabilitation equipment with the E-LITE electric wheelchair and CAREFLEX nursing bed, integrating ergonomic design and smart technology to enhance mobility and care for aging populations. These innovations, alongside a comprehensive range of physiotherapy care and household cleaning products, cater to diverse needs across medical, industrial, and consumer markets, ensuring INTCO remains at the forefront of medical technology.

Sustainability and ESG Leadership

INTCO Medical’s commitment to environmental, social, and governance (ESG) excellence earned it prestigious accolades in 2024, including a WIND Rating A, MSCI ESG Rating BBB, EcoVadis Committed Status, and BSCI certification, which reflect its rigorous standards in ethical production, supply chain management, and corporate responsibility. These efforts position INTCO as a model for sustainable manufacturing in the medical industry, demonstrating that profitability and environmental stewardship can coexist.

Global Reach and Brand Expansion

INTCO Medical strengthened its international footprint through a multi-channel strategy that combined trade show participation, e-commerce dominance, and digital marketing. The company attended over 31 global exhibitions in 2024, where it showcased its medical gloves and rehabilitation equipment to industry professionals. Leveraging social media platforms like TikTok, Facebook, and Chinese e-commerce giants such as Tmall and JD.com， INTCO engaged directly with consumers through localized content and personalized experiences. The company also launched three dedicated B2B websites for medical consumables, rehabilitation devices, and physiotherapy products, supported by multilingual customer service and data-driven marketing to precision-target global markets and enhance brand visibility.

Talent and Organizational Vitality

INTCO Medical’s campus recruitment program brought in over 1,000 graduates in 2024, injecting fresh talent into the company and fostering a culture of innovation. This focus on human capital ensures long-term operational agility, enabling INTCO to adapt to evolving market demands and maintain its competitive edge through cross-functional expertise and creative problem-solving.

Awards and Recognition

In 2024, INTCO Medical received multiple prestigious honors that validated its industry leadership and societal impact, including Anhui Province Outstanding Private Enterprise, Shandong Province Top 200 Private Enterprises, Huaibei City Digital Transformation Benchmark Enterprise, and the New Quality Enterprise Golden Bull Award. These accolades span regional, provincial, and national levels, recognizing the company’s achievements in technological innovation, sustainable development, and corporate citizenship, and reinforcing its reputation as a trusted partner in global healthcare.

Future Outlook: Driving Growth Through Synergy

Looking ahead to 2025, INTCO Medical plans to accelerate its medical consumables, rehabilitation equipment, and physiotherapy care synergistic development model by expanding global manufacturing capacity, particularly in Vietnam and Southeast Asia, to meet rising international demand. The company will also deepen its integration of medical and consumer-oriented products, leveraging data from partnerships like JD Health to develop tailored solutions for home care and personal health. By prioritizing technological innovation and sustainable practices, INTCO aims to redefine the medical supply industry, delivering affordable, high-quality protection and healthcare solutions to customers worldwide while contributing to a healthier, more sustainable future.